Duality of the Immune Response in Cancer: Lessons Learned from Skin

Journal of Investigative Dermatology

Volumn 134, Issue , 2014, Pages E23-E28

  Medler, Terry R ^a   Coussens, Lisa M ^a  

^a OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL; COMPLICATION; CYTOTOXIC T LYMPHOCYTE; CYTOTOXICITY; HUMAN; IMMUNE SYSTEM; IMMUNOLOGY; INFLAMMATION; PHYSIOLOGY; SKIN NEOPLASMS;

ANIMALS; CYTOTOXICITY, IMMUNOLOGIC; HUMANS; IMMUNE SYSTEM; INFLAMMATION; SKIN NEOPLASMS; T-LYMPHOCYTES, CYTOTOXIC;

EID: 84921974687     PISSN: 0022202X     EISSN: 15231747     Source Type: Journal    
DOI: 10.1038/skinbio.2014.5     Document Type: Article

References (46)

1. Affara, N.I., Ruffell, B., Medler, T.R., et al., B cells regulate macrophage phenotype and response to chemotherapy in squamous carcinomas. Cancer Cell 25 (2014), 809–821.
2. Andreu, P., Johansson, M., Affara, N.I., et al. FcRgamma activation regulates inflammation-associated squamous carcinogenesis. Cancer Cell 17 (2010), 121–134.
3. Balkwill, F., Tumour necrosis factor and cancer. Nat Rev Cancer 9 (2009), 361–371.
4. Balkwill, F., Charles, K.A., Mantovani, A., Smoldering and polarized inflammation in the initiation and promotion of malignant disease. Cancer Cell 7 (2005), 211–217.
5. Balkwill, F., Mantovani, A., Inflammation and cancer: back to Virchow?. Lancet 357 (2001), 539–545.
6. Bickels, J., Kollender, Y., Merinsky, O., et al., Coley's toxin: historical perspective. Isr Med Assoc J 4 (2015), 471–472.
7. Bouwes Bavinck, J.N., Kootte, A.M., Van Der Woude, F.J., et al. On a possible protective effect of HLA-A11 against skin cancer and keratotic skin lesions in renal transplant recipients. J Invest Dermatol 97 (1991), 269–272 a.
8. Bouwes Bavinck, J.N., Vermeer, B.J., van der Woude, F.J., et al. Relation between skin cancer and HLA antigens in renal-transplant recipients. N Engl J Med 325 (1991), 843–848 b.
9. Cacalano, G., Lee, J., Kikly, K., Neutrophil and B cell expansion in mice that lack the murine IL-8 receptor homolog. Science 265 (1994), 682–684.
10. Cataisson, C., Pearson, A.J., Tsien, M.Z., et al. CXCR2 ligands and G-CSF mediate PKCalpha-induced intraepidermal inflammation. J Clin Invest 116 (2006), 2757–2766.
11. Chambers, C.A., Kuhns, M.S., Egen, J.G., et al., CTLA-4-mediated inhibition in regulation of T cell responses: mechanisms and manipulation in tumor immunotherapy. Annu Rev Immunol 19 (2001), 565–594.
12. Cheever, M.A., Allison, J.P., Ferris, A.S., et al. The prioritization of cancer antigens: a national cancer institute pilot project for the acceleration of translational research. Clin Cancer Res 15 (2009), 5323–5337.
13. Coley, W.B., Contribution to the knowledge of sarcoma. Ann Surg 14 (1891), 199–220.
14. Coussens, L.M., Raymond, W.W., Bergers, G., et al. Inflammatory mast cells up-regulate angiogenesis during squamous epithelial carcinogenesis. Genes Dev 13 (1999), 1382–1397.
15. Coussens, L.M., Tinkle, C.L., Hanahan, D., et al. MMP-9 supplied by bone marrow-derived cells contributes to skin carcinogenesis. Cell 103 (2000), 481–490.
16. Coussens, L.M., Werb, Z., Inflammatory cells and cancer: think different!. J Exp Med 143 (2001), 23–26.
17. Coussens, L.M., Werb, Z., Inflammation and cancer. Nature 420 (2002), 860–867.
18. Coussens, L.M., Zitvogel, L., Palucka, A.K., Neutralizing tumor-promoting chronic inflammation: a magic bullet?. Science 339 (2013), 286–291.
19. de Visser, K.E., Eichten, A., Coussens, L.M., Paradoxical roles of the immune system during cancer development. Nat Rev Cancer 6 (2006), 24–37.
20. de Visser, K.E., Korets, L.V., Coussens, L.M., De novo carcinogenesis promoted by chronic inflammation is B lymphocyte dependent. Cancer Cell 7 (2005), 411–423.
21. Dvorak, H.F., Tumors: wounds that do not heal. Similarities between tumor stroma generation and wound healing. N Engl J Med 315 (1986), 1650–1659.
22. Emmerich, J., Mumm, J.B., Chan, I.H., et al. IL-10 directly activates and expands tumor-resident CD8(+) T cells without de novo infiltration from secondary lymphoid organs. Cancer Res 72 (2012), 3570–3581.
23. Fortner, G.W., Kripke, M.L., In vitro reactivity of splenic lymphocytes from normal and UV-irradiated mice against syngeneic UV-induced tumors. J Immunol 118 (1977), 1483–1487.
24. Galon, J., Angell, H.K., Bedognetti, D., et al. The continuum of cancer immunosurveillance: prognostic, predictive, and mechanistic signatures. Immunity 39 (2013), 11–26.
25. Girardi, M., Immunosurveillance and immuno-regulation by gammadelta T cells. J Invest Dermatol 126 (2006), 25–31.
26. Girardi, M., Oppenheim, D., Glusac, E.J., et al. Characterizing the protective component of the alphabeta T cell response to transplantable squamous cell carcinoma. J Invest Dermatol 122 (2004), 699–706.
27. Girardi, M., Oppenheim, D.E., Steele, C.R., et al. Regulation of cutaneous malignancy by gammadelta T cells. Science 294 (2001), 605–609.
28. Grabbe, S., Bruvers, S., Gallo, R.L., et al., Tumor antigen presentation by murine epidermal cells. J Immunol 146 (1991), 3656–3661.
29. Hanahan, D., Coussens, L.M., Accessories to the crime: functions of cells recruited to the tumor microenvironment. Cancer Cell 21 (2012), 309–322.
30. Hanahan, D., Weinberg, R.A., Hallmarks of cancer: the next generation. Cell 144 (2011), 646–674.
31. Hardie, I.R., Strong, R.W., Hartley, L.C., et al. Skin cancer in Caucasian renal allograft recipients living in a subtropical climate. Surgery 87 (1980), 177–183.
32. Hartevelt, M.M., Bavinck, J.N., Kootte, A.M., et al. Incidence of skin cancer after renal transplantation in The Netherlands. Transplantation 49 (1990), 506–509.
33. Hodi, F.S., O'Day, S.J., McDermott, D.F., et al., Improved survival with ipilimumab in patients with metastatic melanoma. N Engl J Med 363 (2010), 711–723.
34. Jamieson, T., Clarke, M., Steele, C.W., et al. Inhibition of CXCR2 profoundly suppresses inflammation-driven and spontaneous tumorigenesis. J Clin Invest 122 (2012), 3127–3144.
35. Kaminski, M.J., Cruz, P.D. Jr, Bergstresser, P.R., et al., Killing of skin-derived tumor cells by mouse dendritic epidermal T-cells. Cancer Res 53 (2005), 4014–4019.
36. Lewis, J., Filler, R., Smith, D.A., et al., The contribution of Langerhans cells to cutaneous malignancy. Trends Immunol 31 (2010), 460–466.
37. Modi, B.G., Neustadter, J., Binda, E., et al., Langerhans cells facilitate epithelial DNA damage and squamous cell carcinoma. Science 335 (2012), 104–108.
38. Moore, R.J., Owens, D.M., Stamp, G., et al. Mice deficient in tumor necrosis factor-alpha are resistant to skin carcinogenesis. Nat Med 5 (1999), 828–831.
39. Mumm, J.B., Emmerich, J., Zhang, X., et al., IL-10 elicits IFNgamma-dependent tumor immune surveillance. Cancer Cell 20 (2011), 781–796.
40. Oppenheim, D.E., Roberts, S.J., Clarke, S.L., et al. Sustained localized expression of ligand for the activating NKG2D receptor impairs natural cytotoxicity in vivo and reduces tumor immunosurveillance. Nat Immunol 6 (2005), 928–937.
41. Schioppa, T., Moore, R., Thompson, R.G., et al. B regulatory cells and the tumor-promoting actions of TNF-alpha during squamous carcinogenesis. Proc Natl Acad Sci USA 108 (2011), 10661–10667.
42. Schreiber, H., Ward, P.L., Rowley, D.A., et al., Unique tumor-specific antigens. Annu Rev Immunol 6 (1988), 465–483.
43. Schreiber, R.D., Old, L.J., Smyth, M.J., Cancer immunoediting: integrating immunity's roles in cancer suppression and promotion. Science 331 (2011), 1565–1570.
44. Strid, J., Roberts, S.J., Filler, R.B., et al., Acute upregulation of an NKG2D ligand promotes rapid reorganization of a local immune compartment with pleiotropic effects on carcinogenesis. Nat Immunol 9 (2008), 146–154.
45. Ward, P.L., Koeppen, H., Hurteau, T., et al., Tumor antigens defined by cloned immunological probes are highly polymorphic and are not detected on autologous normal cells. J Exp Med 170 (1989), 217–232.
46. Wing, K., Onishi, Y., Prieto-Martin, P., et al. CTLA-4 control over Foxp3+ regulatory T cell function. Science 322 (2008), 271–275.